Sign in to view content

Assessing Commercially Available Cell Therapies for Retinal Disease in the U.S.

Ajay E Kuriyan, MD, MS
Daniel Simhaee, MD

Video
Published 2018

Related

Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression
Carl D. Regillo, MD
Annual Meeting Talks
2018
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Future DME Therapeutics
Updates from the Field
2017

Category: Hereditary Retinal Disease & Genetics

See more